All In MedTech

FDA Clearance Tracker · P150017-S011

Cartiva Synthetic Cartilage Implant

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jul 12, 2019 (this decision)Source: openFDAMethods & limitations

PMA supplement

The decision

FDA number
P150017-S011
Device name
Cartiva Synthetic Cartilage Implant
Applicant
Cartiva, Inc.
Applicant location
Alpharetta, GA
Received
Jan 15, 2019
Decided
Jul 12, 2019
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Labeling Change - Indications/instructions/shelf life/tradename
Original approval
P150017

Device type

Device class
Class III

Every decision under product code PNW

FDA's approval statement

As written in FDA's record.

Approval for changes to the labeling to reflect the findings of the Post-Approval Study (PAS) protocol.

Source documents

Other decisions for Cartiva, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

2 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.